Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era. [electronic resource]
Producer: 20131125Description: 1513-20 p. digitalISSN:- 1432-0584
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cohort Studies
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Lymphoma, Large B-Cell, Diffuse -- diagnosis
- Male
- Middle Aged
- Models, Biological
- Prednisone -- administration & dosage
- Prognosis
- Rituximab
- Survival Rate -- trends
- Vincristine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.